drugmaker

Gilead to Buy Cancer Drugmaker for $21 Billion
J&J Speeds Up Timeline for Coronavirus Vaccine
Akorn Files for Chapter 11 After Failed Takeover
Gilead to Invest $5B in Galapagos Partnership
Merck Agrees to Buy Peloton Therapeutics
Pfizer Beats Estimates on Strength in Key Drugs
Shire Accepts Improved $62B Bid From Takeda
Novartis to Buy AveXis in $8B Gene Therapy Bet
Teva to Cut 14,000 Jobs in ‘Drastic’ Overhaul
Lilly Veteran Josh Smiley Promoted to CFO
Alexion to Cut 20% of Workforce, Move HQ
Eli Lilly to Trim 3,500 Jobs to Save $500 Million